Cell death pathology: Cross-talk with autophagy and its clinical implications

Biochemical and Biophysical Research Communications

Volumn 414, Issue 2, 2011, Pages 277-281

  Amelio, Ivano ^a   Melino, Gerry ^a,b   Knight, Richard A ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Apoptosis; Autophagy; Cancer; P53; Programmed cell death

Indexed keywords

BECLIN 1; CASPASE; CASPASE 3; CASPASE 7; CASPASE 8; CYTOCHROME C; DEATH RECEPTOR; OBATOCLAX; PEMETREXED; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN BCL XL; SORAFENIB; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTISM; AUTOPHAGY; CANCER CELL CULTURE; CANCER THERAPY; CARCINOMA CELL; CELL INTERACTION; CELL VACUOLE; CELLULAR STRESS RESPONSE; COLON CANCER; CYTOPATHOLOGY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; ERYTHROLEUKEMIA; HUNTINGTON CHOREA; LEUKEMIA CELL LINE; LUNG NON SMALL CELL CANCER; MELANOMA CELL; NERVE DEGENERATION; OXIDATIVE STRESS; PARKINSON DISEASE; PHAGOSOME; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CLEAVAGE; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; T CELL LEUKEMIA; TREATMENT RESPONSE;

AUTOPHAGY; CELL DEATH; CELL SURVIVAL; HUMANS; NEOPLASMS; NEURODEGENERATIVE DISEASES;

EID: 80054839348     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.080     Document Type: Short Survey

References (81)

1. Kroemer G., Galluzzi L., Vandenabeele P., et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009, 16:3-11.
2. Pattingre S., Tassa A., Qu X., et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:922-939.
3. Beau I., Mehrpour M., Codogno P. Autophagosomes and human diseases. Int. J. Biochem. Cell Biol. 2011, 43:460-464.
4. Liang C. Negative regulation of autophagy. Cell Death Differ. 2010, 17:1807-1815.
5. Delgado M.A., Deretic V. Toll-like receptors in control of immunological autophagy. Cell Death Differ. 2009, 16:976-983.
6. Noda T., Fujita N., Yoshimori T. The late stages of autophagy: how does the end begin?. Cell Death Differ. 2009, 16:984-990.
7. Longatti A., Tooze S.A. Vesicular trafficking and autophagosome formation. Cell Death Differ. 2009, 16:956-965.
8. Eisenberg-Lerner A., Bialik S., Simon H.U. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 2009, 16:966-975.
9. Vellai T. Autophagy genes and ageing. Cell Death Differ. 2009, 16:94-102.
10. Kourtis N., Tavernarakis N. Autophagy and cell death in model organisms. Cell Death Differ. 2009, 16:21-30.
11. Maiuri M.C., Tasdemir E., Criollo A., et al. Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ. 2009, 16:87-93.
12. Liang X.H., Jackson S., Seaman M., et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999, 402:672-676.
13. Takahashi Y., Meyerkord C.L., Wang H.G. Bif-1/endophilin B1: a candidate for crescent driving force in autophagy. Cell Death Differ. 2009, 16:947-955.
14. Zhang J., Ney P.A. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ. 2009, 16:939-946.
15. Burton T.R., Gibson S.B. The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death. Cell Death Differ. 2009, 16:515-523.
16. Maiuri M.C., Le Toumelin G., Criollo A., et al. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J. 2007, 26:2527-2539.
17. Tadokoro D., Takahama S., Shimizu K., et al. Characterization of a caspase-3-substrate kinome using an N- and C-terminally tagged protein kinase library produced by a cell-free system. Cell Death Dis. 2010, 1:e89.
18. Cheng J.P., Betin V.M., Weir H., et al. Caspase cleavage of the Golgi stacking factor GRASP65 is required for Fas/CD95-mediated apoptosis. Cell Death Dis. 2010, 1:e82.
19. Wirawan E., VandeWalle L., Kersse K., et al. Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis. 2010, 1:e18.
20. Lee J.S., Li Q., Lee J.Y., et al. FLIP-mediated autophagy regulation in cell death control. Nat. Cell Biol. 2009, 11:1355-1362.
21. Castedo M., Ferri K.F., Kroemer G. Mammalian target of rapamycin (mTOR): pro- and anti-apoptotic. Cell Death Differ. 2002, 9:99-100.
22. Jung C.H., Ro S.H., Cao J., et al. mTOR regulation of autophagy. FEBS Lett. 2010, 7:1287-1295.
23. Silver N., Proctor G.B., Arno M., et al. Activation of mTOR coincides with autophagy during ligation-induced atrophy in the rat submandibular gland. Cell Death Dis. 2010, 1:e14.
24. Kang R., Tang D., Schapiro N.E., et al. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ. 2010, 4:666-676.
25. Melino G., DeLaurenzi V., Vousden K.H. p73: friend or foe in tumorigenesis. Nat. Rev. Cancer 2002, 2:605-615.
26. Schilling T., Schleithoff E.S., Kairat A., et al. Active transcription of the human FAS/CD95/TNFRSF6 gene involves the p53 family. Biochem. Biophys. Res. Commun. 2009, 387:399-404.
27. Tomasini R., Mak T.W., Melino G. The p53 family, aneuploidy and cancer. Trends Cell Biol. 2008, 18:244-252.
28. Gong J.G., Costanzo A., Yang H.Q., et al. Regulation of the p53 homolog p73 by c-Abl tyrosine kinase in cell death response to cisplatin. Nature 1999, 399:806-809.
29. Melino G., Bernassola F., Ranalli M., et al. p73 induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. J. Biol. Chem. 2004, 279:8076-8083.
30. Ramadan S., Terrinoni A., Catani M.V., et al. p73 induces apoptosis by different mechanisms. Biochem. Biophys. Res. Commun. 2005, 331:713-717.
31. Rosenbluth J.M., Mays D.J., Jiang A., et al. Differential regulation of the p73 cistrome by mammalian target of rapamycin reveals transcriptional programs of mesenchymal differentiation and tumorigenesis. Proc. Natl. Acad. Sci. USA 2011, 108:2076-2081.
32. Janson V., Johansson A., Grankvist K. Resistance to caspase-8 and -9 fragments in a malignant pleural mesothelioma cell line with acquired cisplatin-resistance. Cell Death Dis. 2010, 1:e78.
33. Flanagan L., Sebastià J., Tuffy L.P., et al. XIAP impairs Smac release from the mitochondria during apoptosis. Cell Death Dis. 2010, 1:e49.
34. Scheiman J., Jamieson K.V., Ziello J., et al. Extraribosomal functions associated with the C terminus of the 37/67 kDalaminin receptor are required for maintaining cell viability. Cell Death Dis. 2010, 1:e42.
35. Ashkenazi A. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Nat. Rev. Drug Discov. 2008, 12:1001-1012.
36. Schneider-Jakob S., Corazza N., Badmann A., et al. Synergistic induction of cell death in liver tumor cells by TRAIL and chemotherapeutic drugs via the BH3-only proteins Bim and Bid. Cell Death Dis. 2010, 1:e86.
37. Reis C.R., van der Sloot A.M., Natoni A., et al. Rapid and efficient cancer cell killing mediated by high-affinity death receptor homotrimerizing TRAIL variants. Cell Death Dis. 2010, 1:e83.
38. Garzon R., Marcucci G., Croce C.M. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug Discov. 2010, 10:775-789.
39. Acunzo M., Visone R., Romano G., et al. miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. Oncogene 2011, (doi:10.1038/onc.2011.260).
40. Bhatnagar N., Li X., Padi S.K., et al. Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells. Cell Death Dis. 2010, 1:e105.
41. Alajez N.M., Shi W., Hui A.B., et al. Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell Death Dis. 2010, 1:e85.
42. Insabato L., Amelio I., Quarto M., et al. Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors. Oncology 2009, 6:378-384.
43. Chu K.M., Minogue S., Hsuan J.J., et al. Differential effects of the phosphatidylinositol 4-kinases, PI4KIIα and PI4KIIIβ, on Akt activation and apoptosis. Cell Death Dis. 2010, 1:e106.
44. Guardiola-Serrano F., Rossin A., Cahuzac N., et al. Palmitoylation of human FasL modulates its cell death-inducing function. Cell Death Dis. 2010, 1:e88.
45. Jiang C.C., Lai F., Tay K.H., et al. Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS. Cell Death Dis. 2010, 1:e69.
46. Wu P.C., Wang Q., Dong Z.M., et al. Expression of coxsackie and adenovirus receptor distinguishes transitional cancer states in therapy-induced cellular senescence. Cell Death Dis. 2010, 1:e70.
47. Sayeed A., Meng Z., Luciani G., et al. Negative regulation of UCP2 by TGFβ signaling characterizes low and intermediate-grade primary breast cancer. Cell Death Dis. 2010, 1:e53.
48. Hervouet E., Vallette F.M., Cartron P.F. Impact of the DNA methyltransferases expression on the methylation status of apoptosis-associated genes in glioblastomamultiforme. Cell Death Dis. 2010, 1:e8.
49. White E., Karp C., Strohecker A.M., et al. Role of autophagy in suppression of inflammation and cancer. Curr. Opin. Cell Biol. 2010, 22:212-217.
50. Guo J.Y., Chen H.Y., Mathew R., et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 2011, 25:460-470.
51. Rossi M., Munarriz E.R., Bartesaghi S., et al. Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophagic flux. J. Cell Sci. 2009, 122:3330-3339.
52. Amaravadi R.K., Yu D., Lum J.J., et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest. 2007, 117:326-336.
53. Han J., Hou W., Goldstein L.A., et al. Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells. J. Biol. Chem. 2008, 283:19665-19677.
54. Ruela-de-Sousa R.R., Fuhler G.M., Blom N., et al. Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy. Cell Death Dis. 2010, 1:e19.
55. Marino M.L., Fais S., Djavaheri-Mergny M., et al. Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells. Cell Death Dis. 2010, 1:e87.
56. Colell A., Ricci J.E., Tait S., et al. GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspaseactivation. Cell 2007, 129:983-997.
57. Sotelo J., Briceno E., Lopez-Gonzalez M.A. Adding chloroquine to conventional treatment for glioblastomamultiforme: a randomized, double- blind, placebo-controlled trial. Ann. Intern. Med. 2006, 144:337-343.
58. Bareford M.D., Park M.A., Yacoub A., et al. Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. Cancer Res. 2011, 71:4955-4956.
59. McCoy F., Hurwitz J., McTavish N., et al. Obatoclax induces Atg7-dependent autophagy independent of beclin-1 and BAX/BAK. Cell Death Dis. 2010, 1:e108.
60. Heidari N., Hicks M.A., Harada H. GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagy. Cell Death Dis. 2010, 1:e76.
61. Bennett H.L., Fleming J.T., O'Prey J., et al. Androgens modulate autophagy and cell death via regulation of the endoplasmic reticulum chaperone glucose-regulated protein 78/BiP in prostate cancer cells. Cell Death Dis. 2010, 1:e72.
62. Deng L., Feng J., Broaddus R.R. The novel estrogen-induced gene EIG121 regulates autophagy and promotes cell survival under stress. Cell Death Dis. 2010, 1:e32.
63. Sivananthan S.N., Lee A.W., Goodyer C.G., et al. Familial amyloidprecursor protein mutants cause caspase-6-dependent but amyloid β-peptide-independent neuronal degeneration in primary human neuron cultures. Cell Death Dis. 2010, 1:e100.
64. Cordeiro M.F., Guo L., Coxon K.M., et al. Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo. Cell Death Dis. 2010, 1:e3.
65. Sarkar S., Ravikumar B., Floto R.A., et al. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ. 2009, 16:46-56.
66. Seong I.S., Ivanova E., Lee J.M., et al. CAG repeat implicates a dominant property of Huntingtin in mitochondrial energy metabolism. Hum. Mol. Genet. 2005, 14:2871-2880.
67. Saft C., Zange J., Andrich J., et al. Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease. Mov. Disord. 2005, 20:674-679.
68. Sassone J., Colciago C., Marchi P., et al. Mutant Huntingtin induces activation of the Bcl-2/adenovirus E1B 19-kDa interacting protein (BNip3). Cell Death Dis. 2010, 1:e7.
69. Yacoubian T.A., Slone S.R., Harrington A.J., et al. Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease. Cell Death Dis. 2010, 1:e2.
70. Lanzillotta A., Sarnico I., Ingrassia R., et al. The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury. Cell Death Dis. 2010, 1:e96.
71. Yelamanchili S.V., Chaudhuri A.D., Chen L.N., et al. MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological disease. Cell Death Dis. 2010, 1:e77.
72. Fujita E., Dai H., Tanabe Y., et al. Autism spectrum disorder is related to endoplasmic reticulum stress induced by mutations in the synaptic cell adhesion molecule, CADM1. Cell Death Dis. 2010, 1:e47.
73. Mizushima N., Levine B., Cuervo A.M., et al. Autophagy fights disease through cellular self-digestion. Nature 2008, 451:1069-1075.
74. Winslow A.R., Rubinsztein D.C. Autophagy in neurodegeneration and development. Biochim. Biophys. Acta 2008, 1782:723-729.
75. Iwata A., Christianson J.C., Bucci M., et al. Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation. Proc. Natl. Acad. Sci. USA 2005, 102:13135-13140.
76. Ravikumar B., Vacher C., Berger Z., et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 2004, 36:585-595.
77. Cherra S.J., Chu C.T. Autophagy in neuroprotection and neurodegeneration: a question of balance. Future Neurol. 2008, 3:309-323.
78. Lee J.A., Gao F.B. Inhibition of autophagy induction delays neuronal cell loss caused by dysfunctional ESCRT-III in frontotemporal dementia. J. Neurosci. 2009, 29:8506-8511.
79. Li Q., Li H., Roughton K., et al. Lithium reduces apoptosis and autophagy after neonatal hypoxia-ischemia. Cell Death Dis. 2010, 1:e56.
80. Levine B., Klionsky D.J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 2004, 6:463-477.
81. Klionsky D.J. The molecular machinery of autophagy: unanswered questions. J. Cell Sci. 2005, 1:7-18.